Jafron Biomedical (China) Buy Hold or Sell Recommendation
| 300529 Stock | 30.26 0.16 0.53% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Jafron Biomedical Co is 'Sell'. Macroaxis provides Jafron Biomedical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 300529 positions.
Check out Jafron Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Jafron and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Jafron Biomedical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Jafron |
Execute Jafron Biomedical Buy or Sell Advice
The Jafron recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Jafron Biomedical Co. Macroaxis does not own or have any residual interests in Jafron Biomedical Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Jafron Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | OK | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Jafron Biomedical Trading Alerts and Improvement Suggestions
| Jafron Biomedical had very high historical volatility over the last 90 days | |
| Jafron Biomedical is unlikely to experience financial distress in the next 2 years | |
| About 51.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Jafron BiomedicalLtd Seems To Use Debt Rather Sparingly - Simply Wall St |
Jafron Biomedical Returns Distribution Density
The distribution of Jafron Biomedical's historical returns is an attempt to chart the uncertainty of Jafron Biomedical's future price movements. The chart of the probability distribution of Jafron Biomedical daily returns describes the distribution of returns around its average expected value. We use Jafron Biomedical Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Jafron Biomedical returns is essential to provide solid investment advice for Jafron Biomedical.
| Mean Return | 0.36 | Value At Risk | -3.9 | Potential Upside | 6.06 | Standard Deviation | 3.85 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Jafron Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Jafron Biomedical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Dividends Paid | 251.0M | 377.8M | 531.0M | 729.4M | 561.8M | 589.9M | |
| Capital Expenditures | 220.7M | 357.1M | 537.4M | 475.9M | 247.3M | 209.4M | |
| Change To Inventory | (31.2M) | (28.3M) | (75.9M) | (152.7M) | (37.3M) | (39.2M) | |
| Investments | (91.2M) | (4.8M) | (162.5M) | (305.9M) | (249.6M) | (237.2M) | |
| Change In Cash | 190.9M | 303.3M | 744.4M | 211.9M | 215.2M | 306.6M | |
| Depreciation | 29.8M | 36.7M | 52.6M | 74.0M | 94.8M | 99.5M | |
| Net Income | 570.8M | 875.2M | 1.2B | 889.5M | 436.5M | 618.2M | |
| Change To Netincome | (37.9M) | (33.5M) | (15.0M) | (14.1M) | (12.7M) | (13.3M) | |
| End Period Cash Flow | 1.3B | 1.6B | 2.3B | 2.5B | 2.7B | 1.8B | |
| Free Cash Flow | 362.8M | 600.4M | 712.0M | 407.9M | 669.5M | 485.5M | |
| Other Non Cash Items | 1.0M | 2.2M | 13.6M | 44.7M | 72.5M | 76.1M |
Jafron Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Jafron Biomedical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Jafron Biomedical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Jafron stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.30 | |
β | Beta against Dow Jones | 0.36 | |
σ | Overall volatility | 4.08 | |
Ir | Information ratio | 0.06 |
Jafron Biomedical Volatility Alert
Jafron Biomedical Co currently demonstrates below-average downside deviation. It has Information Ratio of 0.06 and Jensen Alpha of 0.3. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Jafron Biomedical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Jafron Biomedical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Jafron Biomedical Fundamentals Vs Peers
Comparing Jafron Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Jafron Biomedical's direct or indirect competition across all of the common fundamentals between Jafron Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Jafron Biomedical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Jafron Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Jafron Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Jafron Biomedical to competition |
| Fundamentals | Jafron Biomedical | Peer Average |
| Return On Equity | 0.25 | -0.31 |
| Return On Asset | 0.11 | -0.14 |
| Profit Margin | 0.31 % | (1.27) % |
| Operating Margin | 0.42 % | (5.51) % |
| Current Valuation | 22.94 B | 16.62 B |
| Shares Outstanding | 798.6 M | 571.82 M |
| Shares Owned By Insiders | 51.06 % | 10.09 % |
| Shares Owned By Institutions | 13.17 % | 39.21 % |
| Price To Book | 7.35 X | 9.51 X |
| Price To Sales | 9.26 X | 11.42 X |
| Revenue | 1.92 B | 9.43 B |
| Gross Profit | 2.27 B | 27.38 B |
| EBITDA | 1.04 B | 3.9 B |
| Net Income | 436.49 M | 570.98 M |
| Total Debt | 261.83 M | 5.32 B |
| Book Value Per Share | 4.25 X | 1.93 K |
| Cash Flow From Operations | 916.74 M | 971.22 M |
| Earnings Per Share | 1.00 X | 3.12 X |
| Target Price | 38.21 | |
| Number Of Employees | 2.41 K | 18.84 K |
| Beta | 0.36 | -0.15 |
| Market Capitalization | 24.38 B | 19.03 B |
| Total Asset | 5.54 B | 29.47 B |
| Retained Earnings | 2 B | 9.33 B |
| Working Capital | 2.48 B | 1.48 B |
| Annual Yield | 0.01 % | |
| Net Asset | 5.54 B | |
| Last Dividend Paid | 0.4 |
Jafron Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Jafron . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 278348.0 | |||
| Daily Balance Of Power | 0.1221 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 30.84 | |||
| Day Typical Price | 30.64 | |||
| Price Action Indicator | (0.49) | |||
| Period Momentum Indicator | 0.16 | |||
| Relative Strength Index | 43.22 |
About Jafron Biomedical Buy or Sell Advice
When is the right time to buy or sell Jafron Biomedical Co? Buying financial instruments such as Jafron Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Jafron Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small & Mid Caps ETFs Thematic Idea Now
Small & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small & Mid Caps ETFs theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Jafron Stock
Jafron Biomedical financial ratios help investors to determine whether Jafron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jafron with respect to the benefits of owning Jafron Biomedical security.